Pro-Dex, Inc.
General ticker "PDEX" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $146.3M (TTM average)
Pro-Dex, Inc. follows the US Stock Market performance with the rate: 56.6%.
Estimated limits based on current volatility of 2.6%: low 59.02$, high 62.23$
Factors to consider:
- Earnings expected soon, date: 2026-10-29 amc
- Total employees count: 206 (+13.8%) as of 2026
- Top business risk factors: Customer concentration, Product development failure, Market acceptance, Labor/talent shortage/retention, Acquisition/divestiture risks
- Current price 13.8% above estimated high
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-06-30 to 2027-06-30
- 2025-06-30 to 2026-06-30 estimated range: [32.59$, 51.89$]
- 2026-06-30 to 2027-06-30 estimated range: [31.91$, 51.21$]
Financial Metrics affecting the PDEX estimates:
- Negative: with PPE of 15.8 at the end of fiscal year the price was high
- Negative: Operating cash flow per share per price, % of -1.20 <= 2.37
- Negative: Industry inventory ratio change (median), % of 1.25 > 1.15
- Negative: 0.33 < Interest expense per share per price, % of 0.59
- Negative: 1.34 < Inventory ratio change, % of 2.76
- Negative: negative Industry operating income (median)
- Negative: Investing cash flow per share per price, % of -0.17 <= -0.14
- Negative: Industry operating cash flow per share per price (median), % of 1.65 <= 3.66
Short-term PDEX quotes
Long-term PDEX plot with estimates
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | $46.09MM | $53.84MM | $66.59MM |
| Operating Expenses | $40.33MM | $46.67MM | $55.90MM |
| Operating Income | $5.76MM | $7.17MM | $10.69MM |
| Non-Operating Income | $3.67MM | $-4.54MM | $1.37MM |
| Interest Expense | $0.53MM | $0.56MM | $0.83MM |
| R&D Expense | $2.80MM | $3.19MM | $3.64MM |
| Income(Loss) | $9.43MM | $2.63MM | $12.06MM |
| Taxes | $2.35MM | $0.51MM | $3.08MM |
| Net Income(Loss)* | $7.07MM | $2.13MM | $8.98MM |
| Stockholders Equity | $31.59MM | $30.87MM | $36.63MM |
| Inventory | $16.17MM | $15.27MM | $22.21MM |
| Assets | $51.82MM | $52.48MM | $61.19MM |
| Operating Cash Flow | $5.46MM | $6.20MM | $-1.68MM |
| Capital expenditure | $0.97MM | $0.98MM | $1.25MM |
| Investing Cash Flow | $-0.89MM | $-2.23MM | $-0.24MM |
| Financing Cash Flow | $-2.49MM | $-4.27MM | $-0.29MM |
| Earnings Per Share** | $1.98 | $0.61 | $2.73 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.